THC Biomed International Ltd. (OTCMKTS:THCBF) reported that it is now permitted by Health Canada to offer dried marihuana to registered people under the ACMPR. The company...
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) released financial report for the third quarter ended June 30, 2017. Justin Gover, the CEO, reported that he is delighted to...
Biogen Inc (NASDAQ:BIIB) announced results from an analysis of the long-term extension of its ongoing Phase 1b trial of aducanumab, the firm’s investigational therapy for early...
Cannabis Science Inc (OTCMKTS:CBIS) and FSO NAC reported that they have commenced the initial harvesting of around 60 acres of industrial hemp on “San Joaquin Sovereign...
SECFilings.com reported the publication of an article showcasing Axim Biotechnologies Inc (OTCMKTS:AXIM) clinical progress and portfolio in light of Zynerba’s Phase II Cannabidiol gel patch failure....
Insys Therapeutics Inc (NASDAQ:INSY) reported that SYNDROS™ has been made available for health care executives to prescribe. It is stocked with most of the key wholesalers...
AbbVie Inc (NYSE:ABBV) released financial report for the second quarter closed June 30, 2017. Richard A. Gonzalez, the CEO and Chairman, reported that they are delighted...
Vitality Biopharma Inc (OTCMKTS:VBIO) reported positive preclinical efficacy data for its gut-targeted cannabosides in the cure of colitis. The company has advanced a new class of...
Vitality Biopharma Inc (OTCMKTS:VBIO) reported that for each of the pharmaceutical offerings in their pipeline, the active Hemp pharmaceutical agents are either now in late-stage clinical...
For the year closed March 2017, Vitality Biopharma Inc (OTCMKTS:VBIO) reported revenue of $163,363 compared to revenue of $248,348 in the same period, a year ago....